BrightGene
BrightGene is a biopharma company.
Business Model:
Revenue: $58.2M
Employees: 0-0
Rankings
Industries / Tags:
Detailed BrightGene Information
Geographic Data
Address: No.218Xinghu Road, SIP
City: Suzhou
State: jiangsu province
Zip: 215000
Country: CN
Financial Info
Stage:
Raised Last:
$80M
Raised Total:$80M
Social
Linkedin
Crunchbase
Metrics
8,577,090Website Global Rank
433Website Monthly Traffic
Twitter Followers
Description
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
Contact Phone:
Contact Email:
BrightGene went public on 11/8/2019 on the SSE
Listed Exchange:
SSE
IPO Date:
11/8/2019
Ticker Symbol:
688166
IPO Price:
$1.816804368335287/share
Amount Raised:
$74M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2018 | DNALite Therapeutics | Seed Round | 0 |
| 7/2020 | Citryll | Series B | 0 |
| 7/2019 | Citryll | Series A | - |
| 7/2020 | Citryll | Series B | 0 |
| 7/2019 | Citryll | Series A | - |
| 8/2018 | DNALite Therapeutics | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
